Clinical Trials
5
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Clinical Trial to Examine Effectiveness of a Human Allograft for Treatment of DFU and VLU
Completed
- Conditions
- Determine Effectiveness of Theraskin in the Treatment of DFU and VLU
- First Posted Date
- 2019-06-26
- Last Posted Date
- 2019-06-28
- Lead Sponsor
- Solsys Medical LLC
- Target Recruit Count
- 188
- Registration Number
- NCT03999281
- Locations
- 🇺🇸
Inova Fairfax Hospital, Fairfax, Virginia, United States
Standard Compression Therapy With/Without Application of Skin Allograft (Theraskin) for Venous Leg Ulcer Treatment
Not Applicable
- Conditions
- Chronic Venous Hypertension With Ulcer
- First Posted Date
- 2019-05-02
- Last Posted Date
- 2019-05-02
- Lead Sponsor
- Solsys Medical LLC
- Target Recruit Count
- 100
- Registration Number
- NCT03935386
- Locations
- 🇺🇸
Inova Fairfax Hospital, Fairfax, Virginia, United States
Comparison of Human Allograft to Apligraf for Venous Leg Ulcers
- Conditions
- Venous Leg Ulcers
- First Posted Date
- 2014-01-28
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Solsys Medical LLC
- Target Recruit Count
- 50
- Registration Number
- NCT02047084
- Locations
- 🇺🇸
St. Francis Wound Healing Center, Greenville, South Carolina, United States
Multi Center Site , Controlled Trial Comparing a Bioengineered Skin Substitute to a Human Skin Allograft
Completed
- Conditions
- Diabetic Foot Ulcer
- First Posted Date
- 2012-08-30
- Last Posted Date
- 2019-06-26
- Lead Sponsor
- Solsys Medical LLC
- Target Recruit Count
- 23
- Registration Number
- NCT01676272
- Locations
- 🇺🇸
Washington Hospital Wound Center, Washington, Pennsylvania, United States
🇺🇸Mary Immaculat Hospital Wound Care Center, Newport News, Virginia, United States
TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers
- First Posted Date
- 2006-10-19
- Last Posted Date
- 2008-05-07
- Lead Sponsor
- Solsys Medical LLC
- Target Recruit Count
- 30
- Registration Number
- NCT00389636
- Locations
- 🇺🇸
Northwestern University, Chicago, Illinois, United States
News
No news found